J-STAR Research Inc., 6 Cedar Brook Dr, Cranbury, NJ 08512, USA.
XtalPi Inc., Shenzhen Jingtai Technology Co., Ltd International Biomedical Innovation Park II 3F, No. 2 Hongliu Road, Futian District, Shenzhen, 518100, China.
Chemistry. 2023 Mar 7;29(14):e202203970. doi: 10.1002/chem.202203970. Epub 2023 Feb 6.
Establishing the absolute configuration of chiral active pharmaceutical ingredients (APIs) is of great importance. Single crystal X-ray diffraction (scXRD) has traditionally been the method of choice for such analysis, but scXRD requires the growth of large crystals, which can be challenging. Here, we present a method for determining absolute configuration that does not rely on the growth of large crystals. By examining microcrystals formed with chiral probes (small chiral compounds such as amino acids), absolute configuration can be unambiguously determined by microcrystal electron diffraction (MicroED). Our streamlined method employs three steps: (1) virtual screening to identify promising chiral probes, (2) experimental cocrystal screening and (3) structure determination by MicroED and absolute configuration assignment. We successfully applied this method to analyze two chiral API molecules currently on the market for which scXRD was not used to determine absolute configuration.
确定手性药物活性成分 (API) 的绝对构型非常重要。单晶 X 射线衍射 (scXRD) 一直是此类分析的首选方法,但 scXRD 需要生长大晶体,这可能具有挑战性。在这里,我们提出了一种不依赖于大晶体生长的确定绝对构型的方法。通过检查用手性探针形成的微晶体(如氨基酸等小的手性化合物),可以通过微晶体电子衍射 (MicroED) 来明确确定绝对构型。我们的简化方法采用三个步骤:(1)虚拟筛选以识别有前途的手性探针,(2)实验共晶筛选和(3)通过 MicroED 进行结构确定和绝对构型分配。我们成功地将该方法应用于分析目前市场上两种未使用 scXRD 确定绝对构型的手性 API 分子。